Ascendis Pharma A/S Selling, General and Administrative Expense
Ascendis Pharma A/S (ASND) reported Selling, General and Administrative Expense of EUR 457.87 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SellingGeneralAndAdministrativeExpense · last filed 2026-02-11
- Ascendis Pharma A/S selling general and administrative expense for the quarter ending 2025-12-31 was 135.85M EUR, a 69.37% increase year-over-year.
- Ascendis Pharma A/S selling general and administrative expense for the quarter ending 2025-09-30 was 113.40M EUR, a 62.40% increase year-over-year.
- Ascendis Pharma A/S selling general and administrative expense for the quarter ending 2025-06-30 was 107.56M EUR, a 44.74% increase year-over-year.
- Ascendis Pharma A/S selling general and administrative expense for the quarter ending 2025-03-31 was 101.05M EUR, a 51.30% increase year-over-year.
| Period end | Selling General And Administrative Expense 3 month | Selling General And Administrative Expense 6 month | Selling General And Administrative Expense 9 month | Selling General And Administrative Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | 135.85M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 249.26M EUR derived: sum of 2 quarters · filed 2026-02-11 | 356.82M EUR derived: sum of 3 quarters · filed 2026-02-11 | 457.87M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 113.40M EUR 6-K · filed 2025-11-12 | 220.97M EUR derived: sum of 2 quarters · filed 2025-11-12 | 322.01M EUR 6-K · filed 2025-11-12 | 402.23M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | 107.56M EUR 6-K · filed 2025-08-07 | 208.61M EUR 6-K · filed 2025-08-07 | 288.82M EUR derived: sum of 3 quarters · filed 2026-02-11 | 358.65M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | 101.05M EUR 6-K · filed 2025-05-01 | 181.26M EUR derived: sum of 2 quarters · filed 2026-02-11 | 251.09M EUR derived: sum of 3 quarters · filed 2026-02-11 | 325.40M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-31 | 80.21M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 150.04M EUR derived: sum of 2 quarters · filed 2026-02-11 | 224.36M EUR derived: sum of 3 quarters · filed 2026-02-11 | 291.14M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 69.83M EUR 6-K · filed 2025-11-12 | 144.14M EUR derived: sum of 2 quarters · filed 2025-11-12 | 210.93M EUR 6-K · filed 2025-11-12 | 274.90M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | 74.31M EUR 6-K · filed 2025-08-07 | 141.09M EUR 6-K · filed 2025-08-07 | 205.07M EUR derived: sum of 3 quarters · filed 2026-02-11 | 268.68M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | 66.78M EUR 6-K · filed 2025-05-01 | 130.76M EUR derived: sum of 2 quarters · filed 2026-02-11 | 194.37M EUR derived: sum of 3 quarters · filed 2026-02-11 | 264.65M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | 63.98M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 127.59M EUR derived: sum of 2 quarters · filed 2026-02-11 | 197.87M EUR derived: sum of 3 quarters · filed 2026-02-11 | 264.41M EUR 20-F · filed 2026-02-11 |
| 2023-09-30 | 63.61M EUR 6-K · filed 2024-11-14 | 133.90M EUR derived: sum of 2 quarters · filed 2024-11-14 | 200.44M EUR 6-K · filed 2024-11-14 | 256.99M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | 70.28M EUR 6-K · filed 2024-09-03 | 136.82M EUR 6-K · filed 2024-09-03 | 193.37M EUR derived: sum of 3 quarters · filed 2025-02-12 | 254.04M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | 66.54M EUR 6-K · filed 2024-05-02 | 123.09M EUR derived: sum of 2 quarters · filed 2025-02-12 | 183.76M EUR derived: sum of 3 quarters · filed 2025-02-12 | 240.35M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | 56.55M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | 117.22M EUR derived: sum of 2 quarters · filed 2025-02-12 | 173.81M EUR derived: sum of 3 quarters · filed 2025-02-12 | 221.23M EUR 20-F · filed 2025-02-12 |
| 2022-09-30 | 60.67M EUR 6-K · filed 2023-11-07 | 117.25M EUR derived: sum of 2 quarters · filed 2023-11-07 | 164.68M EUR 6-K · filed 2023-11-07 | 212.98M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | 56.58M EUR 6-K · filed 2023-09-05 | 104.00M EUR 6-K · filed 2023-09-05 | 152.31M EUR derived: sum of 3 quarters · filed 2024-02-07 | 191.59M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | 47.42M EUR 6-K · filed 2023-04-27 | 95.72M EUR derived: sum of 2 quarters · filed 2024-02-07 | 135.01M EUR derived: sum of 3 quarters · filed 2024-02-07 | 170.35M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | 48.30M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07 | 87.59M EUR derived: sum of 2 quarters · filed 2024-02-07 | 122.93M EUR derived: sum of 3 quarters · filed 2024-02-07 | 160.18M EUR 20-F · filed 2024-02-07 |
| 2021-09-30 | 39.28M EUR 6-K · filed 2022-11-02 | 74.63M EUR derived: sum of 2 quarters · filed 2022-11-02 | 111.88M EUR 6-K · filed 2022-11-02 | 132.30M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | 35.34M EUR 6-K · filed 2022-08-10 | 72.59M EUR 6-K · filed 2022-08-10 | 93.02M EUR derived: sum of 3 quarters · filed 2023-02-16 | 110.54M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | 37.25M EUR 6-K · filed 2022-05-11 | 57.67M EUR derived: sum of 2 quarters · filed 2023-02-16 | 75.20M EUR derived: sum of 3 quarters · filed 2023-02-16 | 96.00M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | 20.43M EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-16 | 37.95M EUR derived: sum of 2 quarters · filed 2023-02-16 | 58.75M EUR derived: sum of 3 quarters · filed 2023-02-16 | 76.67M EUR 20-F · filed 2023-02-16 |
| 2020-09-30 | 17.52M EUR 6-K · filed 2021-11-10 | 38.33M EUR derived: sum of 2 quarters · filed 2021-11-10 | 56.24M EUR 6-K · filed 2021-11-10 | 73.32M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-06-30 | 20.80M EUR 6-K · filed 2021-08-27 | 38.72M EUR 6-K · filed 2021-08-27 | 55.80M EUR derived: sum of 3 quarters · filed 2022-03-02 | 65.80M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-03-31 | 17.91M EUR 6-K · filed 2021-05-27 | 34.99M EUR derived: sum of 2 quarters · filed 2022-03-02 | 44.99M EUR derived: sum of 3 quarters · filed 2022-03-02 | 55.95M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2019-12-31 | 17.08M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-03-02 | 27.08M EUR derived: sum of 2 quarters · filed 2022-03-02 | 38.04M EUR derived: sum of 3 quarters · filed 2022-03-02 | 48.47M EUR 20-F · filed 2022-03-02 |
| 2019-09-30 | 10.00M EUR 6-K · filed 2020-11-12 | 20.96M EUR derived: sum of 2 quarters · filed 2020-11-12 | 31.40M EUR 6-K · filed 2020-11-12 | 39.77M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | 10.96M EUR 6-K · filed 2020-08-27 | 21.40M EUR 6-K · filed 2020-08-27 | 29.77M EUR derived: sum of 3 quarters · filed 2021-03-10 | 36.56M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | 10.44M EUR 6-K · filed 2020-05-19 | 18.81M EUR derived: sum of 2 quarters · filed 2021-03-10 | 25.61M EUR derived: sum of 3 quarters · filed 2021-03-10 | 30.83M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | 8.37M EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-10 | 15.17M EUR derived: sum of 2 quarters · filed 2021-03-10 | 20.39M EUR derived: sum of 3 quarters · filed 2021-03-10 | 25.06M EUR 20-F · filed 2021-03-10 |
| 2018-09-30 | 6.80M EUR 6-K · filed 2019-11-18 | 12.02M EUR derived: sum of 2 quarters · filed 2019-11-18 | 16.68M EUR 6-K · filed 2019-11-18 | 20.77M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-06-30 | 5.23M EUR 6-K · filed 2019-08-28 | 9.89M EUR 6-K · filed 2019-08-28 | 13.97M EUR derived: sum of 3 quarters · filed 2020-04-03 | 16.81M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-03-31 | 4.66M EUR 6-K · filed 2019-05-30 | 8.75M EUR derived: sum of 2 quarters · filed 2020-04-03 | 11.59M EUR derived: sum of 3 quarters · filed 2020-04-03 | 14.82M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2017-12-31 | 4.09M EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-04-03 | 6.93M EUR derived: sum of 2 quarters · filed 2020-04-03 | 10.16M EUR derived: sum of 3 quarters · filed 2020-04-03 | 13.48M EUR 20-F · filed 2020-04-03 |
| 2017-09-30 | 2.84M EUR 6-K · filed 2018-11-28 | 6.07M EUR derived: sum of 2 quarters · filed 2018-11-28 | 9.40M EUR 6-K · filed 2018-11-28 | |
| 2017-06-30 | 3.23M EUR 6-K · filed 2018-08-29 | 6.56M EUR 6-K · filed 2018-08-29 | ||
| 2017-03-31 | 3.33M EUR 6-K · filed 2018-05-30 | |||
| 2016-12-31 | 11.50M EUR 20-F · filed 2019-04-03 | |||
| 2015-12-31 | 9.41M EUR 20-F · filed 2018-03-28 |